Ann: Paradigm Launches A$77.9M Capital Raise, page-2

Paradigm Biopharmaceuticals (ASX: PAR) 15 April 2019: ASX listed biotechnology company

Paradigm Pharmaceuticals Limited (ASX: PAR, “Paradigm” or the “Company” is pleased to announce the launch of a A$77.9m capital raise (“Offer”. The Offer comprises a $51.6m placement to professional, institutional and sophisticated investors across Australia, Asia and the US including some existing shareholders(“Placement” and a $26.3m underwritten 1 for 8 accelerated non renounceable entitlement offer (“Entitlement Offer” to all eligible shareholders registered with an address in Australia or New Zealand as at the Record Date (namely 7.00pm Wednesday 17 April),

Think i will grab a few more by 17th!